Form 4: Clorox Director Spencer C. Fleischer Reports Acquisition of Deferred Stock Units
SEC Form 4 Filing
Director Spencer C. Fleischer reports acquiring deferred stock units in Clorox through dividend reinvestment and in lieu of director's fees.
Summary
- Spencer C. Fleischer, a director of Clorox, reported acquiring deferred stock units.
- On February 14, 2025, 145.4207 deferred stock units were acquired through dividend reinvestment.
- On March 31, 2025, 212.2241 deferred stock units were acquired in lieu of quarterly director's fees.
- The deferred stock units will be settled in Clorox stock upon the director's retirement or termination of service.
- Following these transactions, Fleischer beneficially owns 17,989.304 deferred stock units.
Sentiment
Score: 7
Explanation: The document reflects standard director compensation practices, indicating stability and alignment of interests. It is neither overly positive nor negative.
Future Outlook
The deferred stock units will be settled 100% in Clorox stock upon the director's retirement or termination of service.
Industry Context
This filing reflects routine compensation practices for board members, aligning their interests with long-term shareholder value through equity-based compensation.
Comparison to Industry Standards
- Equity compensation for board members is a common practice across publicly traded companies.
- Companies like Procter & Gamble (PG) and Unilever (UL) also utilize stock and option grants as part of their director compensation packages.
- The specific amount and type of equity compensation can vary based on company size, performance, and industry standards.
Stakeholder Impact
- The acquisition of deferred stock units aligns the director's interests with those of shareholders, promoting long-term value creation.
- This type of compensation is a standard practice and is unlikely to have a significant impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/14/2025 | Acquisition of 145.4207 deferred stock units through dividend reinvestment. |
| 03/31/2025 | Acquisition of 212.2241 deferred stock units in lieu of quarterly director's fees. |
| 04/02/2025 | Date of signature for the Form 4 filing. |
Keywords
Clorox, Director, Deferred Stock Units, Dividend Reinvestment, Form 4, SEC, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.